FREMONT, Calif.--(BUSINESS WIRE)--Nov. 8, 2005--FlowMedica, Inc., a medical device company developing catheter-based systems to apply targeted renal therapy (TRT(TM)) to prevent and treat kidney dysfunction that results from certain interventional or surgical procedures and diseases, today announced the closing of a $15 million series D financing round.
